Serum biomarkers for the evaluation of liver fibrosis: The need for better tests
- PMID: 30249549
- PMCID: PMC6284626
- DOI: 10.5152/tjg.2018.260618
Serum biomarkers for the evaluation of liver fibrosis: The need for better tests
Comment on
-
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.Turk J Gastroenterol. 2018 Jul;29(4):464-472. doi: 10.5152/tjg.2018.16597. Turk J Gastroenterol. 2018. PMID: 30249562 Free PMC article.
References
-
- Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol. 2003;38( Suppl 1):S38–53. - PubMed
-
- Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut. 2010;59:861–6. - PubMed
-
- Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53:325–35. - PubMed
-
- Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293–302. - PubMed
-
- Adams LA. Biomarkers of liver fibrosis. J Gastroenterol Hepatol. 2011;26:802–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical